Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

13.6%

498 terminated/withdrawn out of 3666 trials

Success Rate

81.1%

-5.4% vs industry average

Late-Stage Pipeline

9%

313 trials in Phase 3/4

Results Transparency

36%

778 of 2134 completed trials have results

Key Signals

584 recruiting778 with results316 terminated182 withdrawn

Enrollment Performance

Analytics

N/A
1413(51.9%)
Phase 2
467(17.2%)
Phase 1
430(15.8%)
Phase 4
204(7.5%)
Phase 3
109(4.0%)
Early Phase 1
98(3.6%)
2721Total
N/A(1413)
Phase 2(467)
Phase 1(430)
Phase 4(204)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3666)

Showing 20 of 3666 trials
NCT04816006Not ApplicableRecruiting

Breast Cancer, Reasoning, and Activity Intervention

Role: lead

NCT05328934Not ApplicableCompleted

SoftHand Comparison Study

Role: lead

NCT05167721Phase 2Active Not Recruiting

Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy

Role: lead

NCT07643844Phase 1Not Yet Recruiting

AAVrh10-PCCA Gene Therapy for Propionic Acidemia

Role: lead

NCT03618186Phase 2Enrolling By Invitation

Neuroimaging Study

Role: lead

NCT05557877Phase 2Recruiting

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Role: lead

NCT05240807Not ApplicableCompleted

Clinical Impact of Cardiac Photon-Counting Detector CT

Role: lead

NCT07644702Not ApplicableRecruiting

WE-CARE Community Health Forums to Increase Breast Cancer Screening and Clinical Trial Participation for Rural and Low Income Women

Role: lead

NCT07612007Phase 2Not Yet Recruiting

HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization

Role: lead

NCT06887829Not ApplicableRecruiting

Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial

Role: lead

NCT05666960Phase 1Recruiting

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Role: collaborator

NCT02437526Not ApplicableEnrolling By Invitation

Analytic Treatment Interruption (ATI) to Assess HIV Cure

Role: lead

NCT06657001Enrolling By Invitation

Enabling Microbiomics- Driven Personalized Nutrition

Role: lead

NCT04567771Not ApplicableActive Not Recruiting

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

Role: lead

NCT05193968Not ApplicableRecruiting

Hot Flashes and Neurovascular Function in Women

Role: lead

NCT06770049Not ApplicableRecruiting

Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial

Role: lead

NCT06814938Phase 4Active Not Recruiting

A Study of a Novel Precision Medicine Approach For Obesity

Role: lead

NCT03017820Phase 1Recruiting

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

Role: lead

NCT06508463Phase 1Recruiting

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

Role: lead

NCT06788886Not ApplicableRecruiting

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

Role: lead